In the Campylobacter Infections Therapeutics Market, the treatment landscape is dominated by antibiotics. The most commonly used drugs for treating Campylobacter infections are macrolides (like azithromycin) and fluoroquinolones (such as ciprofloxacin). However, the development of antibiotic-resistant strains of Campylobacter has prompted the need for alternative therapeutic approaches....